The Beachbody Company (BODY) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached $110.2M, surpassing the midpoint of guidance, with net loss and Adjusted EBITDA both better than guidance.
Achieved the lowest net loss since going public and third consecutive quarter of positive Adjusted EBITDA.
Gross margin reached 69%, the highest since 2021, with digital fitness gross margin at 81% and nutrition at 61%.
Revenue declined 18% year-over-year, with digital, nutrition, and connected fitness segments all down; digital subscriptions fell to 1.15M and nutrition to 0.14M.
Strategic focus is shifting to the nutrition market, leveraging historical strength and high margins.
Financial highlights
Q2 2024 revenue was $110.2M, down 18% year-over-year; digital revenue was $58.8M (down 10%), nutrition $50.1M (down 22%), connected fitness $1.3M (down 74%).
Gross profit was $76.4M, with overall gross margin at 69.3%, up from 61.3% prior year.
Net loss was $10.9M, improved from $25.7M a year ago; Adjusted EBITDA was $4.9M, up from a $4.8M loss.
Operating expenses for Q2 were $85.9M, down from $106.9M prior year.
Cash and cash equivalents at June 30, 2024 were $32.3M; net cash position was $10.9M.
Outlook and guidance
Q3 2024 revenue expected between $97M and $107M.
Net loss guidance for Q3 is $13M to $9M; Adjusted EBITDA expected between $2M and $15M.
Management expects to remain in compliance with financial covenants, but cushion for minimum revenue covenants is expected to narrow.
Continued focus on innovation pipeline and returning to revenue growth in late 2024 and 2025.
Latest events from The Beachbody Company
- Turnaround success and retail expansion set the stage for accelerated growth in 2027.BODY
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference3 Jun 2026 - Turnaround success: multi-channel strategy, retail launches, and 10 straight profitable quarters.BODY
16th Annual LD Micro Invitational Conference21 May 2026 - Turnaround success with multi-channel strategy, strong financials, and new product launches.BODY
Investor presentation18 May 2026 - Third consecutive profitable quarter with $2.3M net income, margin gains, and retail expansion.BODY
Q1 202612 May 2026 - Board recommends approval of director slate, auditor, and executive compensation at annual meeting.BODY
Proxy filing23 Apr 2026 - Virtual annual meeting to vote on board, auditor, and executive pay, with board support for all.BODY
Proxy filing23 Apr 2026 - Turnaround success with new multi-channel strategy, strong financials, and innovative product launches.BODY
Investor presentation24 Mar 2026 - Achieved profitability, positive cash flow, and launched new products despite revenue decline.BODY
Q4 202510 Mar 2026 - Turnaround strategy leverages hybrid sales, cost cuts, and innovation to drive profitable growth.BODY
Virtual Consumer Company Showcase3 Feb 2026